Physician

Betty R Klein, MD

According to 2025 Medicare claims, Betty Klein, MD (NPI: 1215992490) practices ophthalmology in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is EYE ASSOCIATES OF NEW MEXICO LTD (NPI: 1104868520; TIN: 85-0246856) and primary practice location at 87505-6303.

Klein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 999 traditional Medicare patients, billed 50,627 HCPCS/CPT codes, and received $3,004,378 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 830 prescription claims across 220 beneficiaries totaling $44,469 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 8 records totaling $216. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $128,092 to $44,469. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $1,581,663 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,546,321 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,556,514 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,519,690 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,561,997 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,193,991 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $821,315 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,059,926 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,430,146 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,004,378 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158387,506$1,581,663
20168787,735$1,546,321
20178597,710$1,556,514
20188207,634$1,519,690
20197547,862$1,561,997
20206015,774$1,193,991
20215243,862$821,315
202263010,305$2,059,926
202386131,357$2,430,146
202499950,627$3,004,378

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$103K$205K2015 Drug cost: $128,092 (USD; Tot_Drug_Cst)2016 Drug cost: $137,297 (USD; Tot_Drug_Cst)2017 Drug cost: $162,512 (USD; Tot_Drug_Cst)2018 Drug cost: $180,828 (USD; Tot_Drug_Cst)2019 Drug cost: $199,557 (USD; Tot_Drug_Cst)2020 Drug cost: $205,285 (USD; Tot_Drug_Cst)2021 Drug cost: $193,842 (USD; Tot_Drug_Cst)2022 Drug cost: $59,251 (USD; Tot_Drug_Cst)2023 Drug cost: $43,423 (USD; Tot_Drug_Cst)2024 Drug cost: $44,469 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152251,113$128,092
20162521,416$137,297
20172651,466$162,512
20182471,390$180,828
20192451,255$199,557
20202191,192$205,285
2021175925$193,842
2022162431$59,251
2023191713$43,423
2024220830$44,469

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3391,702$650
67028Injection of drug into eye6491,877$87
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more395451$66
J2777Injection, faricimab-svoa, 0.1 mg21142,060$27
92134Imaging of retina8251,310$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast14480$10,476
Prednisolone AcetatePrednisolone Acetate1645,426$5,505
LumiganBimatoprost12320$2,964
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14760$2,828
Loteprednol EtabonateLoteprednol Etabonate14438$2,483

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$216ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Betty R. Klein, MD?

Tedicare shows public-source Medicare data for Betty R. Klein, MD (NPI 1215992490), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Betty R. Klein, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Betty R. Klein, MD?

Betty R. Klein, MD is linked to EYE ASSOCIATES OF NEW MEXICO LTD (billing NPI 1104868520) in the available physician profile data.

Does Betty R. Klein, MD have Open Payments data?

Betty R. Klein, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.